Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study

PURPOSE: Primary pulmonary lympho-epithelioma-like carcinoma (PPLELC) is a rare subtype of primary non-small cell lung cancer (NSCLC). Currently, there is still lack of research data on anti-angiogenic therapy of advanced PPLELC. The purpose of this study was to investigate the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Hejing, Ma, Ling Zhen, Zhao, Chengzhu, Yu, Mengge, Zhang, Baishen, Zhang, Juan, Peng, Guibao, Lin, Xiaotong, Fang, Yinhua, Bao, Hehong, Ma, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984323/
https://www.ncbi.nlm.nih.gov/pubmed/35377040
http://dx.doi.org/10.1007/s00432-022-03935-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984323/
https://www.ncbi.nlm.nih.gov/pubmed/35377040
http://dx.doi.org/10.1007/s00432-022-03935-0

Ejemplares similares